Search

Your search keyword '"Porwal, Sanjay"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Porwal, Sanjay" Remove constraint Author: "Porwal, Sanjay"
118 results on '"Porwal, Sanjay"'

Search Results

1. Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis

2. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

3. Ultranarrow Band UV Detection in GaN with Simple Device Architecture.

4. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

7. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

9. Comparison of left ventricular volume and left ventricular ejection fraction by 2-dimensional echocardiography by Simpson’s method & real time 3-dimensional echocardiography in patients of normal conduction with normal left ventricular function, complete left bundle branch block with normal left ventricular function and with left ventricular dysfunction

13. The Effect of an Accelerated Renal Replacement Therapy Initiation Is Not Modified by Baseline Risk

14. MicroRNA 24 as predictor of CAD severity in patients with Acute Coronary syndrome with and without Diabetes mellitus.

17. A Bayesian reanalysis of the standard versus accelerated initiation of renal-replacement therapy in acute kidney injury (STARRT-AKI) trial

22. Teasers and Tips

25. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

26. Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial

27. Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

28. Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

31. ASSESSMENT OF AORTIC VALVE SCLEROSIS AS A MARKER OF CORONARY ARTERY DISEASE AND ITS RISK FACTORS

32. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

33. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

43. Lembe Study: Left Main PCI in Belgaum

45. Role of ZrO2 Passivation Layer Thickness in the Fabrication of High-Responsivity GaN Ultraviolet Photodetectors.

46. WITHDRAWN: LEMBE study: Left main PCI in Belgaum Registry

Catalog

Books, media, physical & digital resources